Approximately 2 wk after birth, mice having a TGF-beta 1 null mutation
(TGF-beta 1(-/-)) exhibit a progressive wasting syndrome and death. A
ssociated with this phenotype is a multifocal infiltration of lymphocy
tes and macrophages into targeted organs, especially the heart, lungs,
and salivary glands. To explore the consequences of TGF-beta 1 defici
ency on the immune system, lymphocyte phenotype and function were anal
yzed. Initially, lymphoid organ architecture seemed to be normal and,
as symptoms developed, the thymus decreased in size, whereas lymph nod
es were enlarged. Phenotypically, the TGF-beta 1(-/-) lymphoid cells s
eemed to be more differentiated in the thymus and activated in the lym
ph nodes, but remarkably unaffected in the spleen. Moreover, TGF-beta
1(-/-) spleen and lymph nodes displayed enhanced numbers of proliferat
ing cells, as measured by proliferating cell nuclear Ag and/or cyclin-
dependent kinase levels. Consistent with this hyperproliferative respo
nse, constitutive levels of IL-2 mRNA were elevated in the thymus and
both IL-2 and IL-2R mRNA were increased in the lymph nodes. In contras
t with the activation profile of TGF-beta 1(-/-) lymphoid cells in viv
o, mitogen challenge of these cells in vitro revealed suppressed proli
feration that was associated with a defect in inducible IL-2 mRNA expr
ession and IL-2 secretion. Moreover, the addition of rIL-2 restored th
e deficient mitogen-induced proliferation. The mechanism leading to T
cell anergy remains unclear; however, these data confirm the essential
role for TGF-beta 1 in maintaining normal immune function.